KOHLMEIER-DEGOS DISEASE

Clinical trials for KOHLMEIER-DEGOS DISEASE explained in plain language.

Never miss a new study

Get alerted when new KOHLMEIER-DEGOS DISEASE trials appear

Sign up with your email to follow new studies for KOHLMEIER-DEGOS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

First-Ever trial for deadly degos disease targets brain lesions

Disease control Recruiting now

This study is testing if the drug baricitinib can slow or stop the progression of brain and spine lesions in people with Kohlmeier-Degos disease, a rare and often fatal condition with no existing treatment. The trial will enroll 12 adults who already have neurological involvement…

Matched conditions: KOHLMEIER-DEGOS DISEASE

Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

KOHLMEIER-DEGOS DISEASE

Get alerted when new KOHLMEIER-DEGOS DISEASE trials appear

First-Ever trial for deadly degos disease targets brain lesions